Orthofix

Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Our products are distributed in more than 70 countries around the world via Orthofix sales representatives, distributors and subsidiaries.

Founded in Verona, Italy in 1980, Orthofix has approximately 900 employees around the world who are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. Many of our innovative product offerings were cultivated through affiliations with surgeons and premiere health care organizations. Orthofix is proud to collaborate on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation (MTF) and the Texas Scottish Rite Hospital for Children.

Revenue(Q1, 2017)

$102.7 M

Market capitalization(2017-07-25)

$828.6 M

Company Growth (employees)

Type

Public

Z.A.I., IT

Founded

1980

Size (employees)

938 (est)

Website

orthofix.com

Orthofix was founded in 1980 and is headquartered in Z.a.i., IT

Orthofix Office Locations

Orthofix has offices in Z.a.i., Willemstad, Sona, São Paulo and in 5 other locations

Z.a.i., IT (HQ)

9 Via delle Nazioni

San Juan, PR

970 Cll 21 SE

Maidenhead, GB

Clivemont Rd

Lewisville, US

3451 Plano Pkwy

Arcueil, FR

28 Villa Baudran

Ottobrunn, DE

5 Siemensstraße

Orthofix Data and Metrics

Orthofix Financial Metrics

Orthofix's revenue was reported to be $102.7 m in Q1, 2017

Summary

USD

Orthofix's current market capitalization is $828.6 m.

Income Statement

Annual

USD	FY, 2016
Revenue	409.8 m
Cost of goods sold	87.9 m
Gross profit	321.9 m
Gross profit Margin, %	79%
Sales and marketing expense	181.3 m
R&D expense	28.8 m
General and administrative expense	74.4 m
Operating expense total	284.5 m
EBIT	21.1 m
EBIT margin, %	5%
Interest expense	763 k
Interest income	763 k
Pre tax profit	19 m
Income tax expense	(15.5 m)
Net Income	3.1 m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Revenue	101 m	101 m	89.8 m	101 m	101.2 m	98.7 m	104.1 m	98.5 m	102.7 m
Cost of goods sold	25.4 m	25.3 m	19.3 m	21.9 m	23.9 m	22.1 m	22.5 m	19.9 m	22.6 m
Gross profit	75.6 m	75.7 m	70.4 m	79 m	77.3 m	76.5 m	81.6 m	78.6 m	80.2 m
Gross profit Margin, %	75%	75%	78%	78%	76%	78%	78%	80%	78%
Sales and marketing expense	42 m	41 m	44.3 m	42.9 m	46.1 m	44.8 m	46 m	41.7 m	48.5 m
R&D expense	6.3 m	6.6 m	5.8 m	6.5 m	6.5 m	7.6 m	6.8 m	6.9 m	7.4 m
General and administrative expense	17.6 m	18.8 m	21.2 m	22.5 m	19.3 m	16.7 m	18 m	18.6 m	18.3 m
Operating expense total	65.9 m	66.4 m	71.3 m	71.9 m	72 m	69.2 m	70.8 m	67.2 m	74.2 m
EBIT	6.7 m	6.5 m	(7.2 m)	4.9 m	4.1 m	7.1 m	(2.6 m)	9.3 m	5.9 m
EBIT margin, %	7%	6%	(8%)	5%	4%	7%	(3%)	9%	6%
Interest expense	(492 k)	(395 k)	(272 k)	74 k	(125 k)	(38 k)		471 k	45 k
Interest income				74 k				471 k	45 k
Pre tax profit	6.6 m	4.8 m	(6.8 m)	5.9 m	2.3 m	8.9 m	(2.6 m)	9.1 m	1.6 m
Income tax expense	(3.3 m)	(4.8 m)	(964 k)	(1.8 m)	(3.1 m)	(4.3 m)	(3.7 m)	1.3 m	(3.9 m)
Net Income	(683 k)	452 k	(8.4 m)	3.6 m	(1.4 m)	3.9 m	(7.4 m)	9.9 m	(2.7 m)

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	30.5 m	36.8 m	63.7 m	39.6 m
Accounts Receivable				2.8 m
Inventories	90.6 m	59.8 m	57.6 m	63.3 m
Current Assets	280.2 m	256.4 m	212.3 m	194.4 m
PP&E	54.6 m	48.5 m	52.3 m	48.9 m
Goodwill	53.6 m	53.6 m	53.6 m	53.6 m
Total Assets	423.2 m	393.2 m	400.2 m	372.1 m
Accounts Payable	20.7 m	13.2 m	16.4 m	14.4 m
Current Liabilities	66.8 m	66.4 m	82 m	83.4 m
Total Liabilities				108.6 m
Additional Paid-in Capital	216.7 m	232.8 m	232.1 m	204.1 m
Retained Earnings	89.3 m	65.4 m	62.6 m	64.2 m
Total Equity	310.5 m		290.3 m	263.5 m
Financial Leverage	1.4 x		1.4 x	1.4 x

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Cash	28.9 m	29.8 m	29.8 m	55.9 m	63.7 m	39.8 m	40.5 m	46.8 m	41.7 m
Inventories	70.9 m	64.3 m	56.7 m	59.2 m	57.8 m	59.8 m	61.3 m	65 m	66.3 m
Current Assets	292.7 m	270.3 m	235 m	235.2 m	245.5 m	174 m	178 m	185.2 m	186.8 m
PP&E	51.1 m	49.6 m	46.7 m	50 m	51.5 m	53.6 m	52.5 m	51.9 m	48 m
Goodwill	53.6 m	53.6 m	53.6 m	53.6 m	53.6 m	53.6 m	53.6 m	53.6 m	53.6 m
Total Assets	434 m	411 m	386.7 m	389.2 m	402.4 m	362.8 m	364.7 m	376.1 m	354.7 m
Accounts Payable	15.7 m	13.2 m	16.3 m	17.2 m	17 m	13.5 m	13.7 m	14.4 m	16.6 m
Current Liabilities	83.1 m	81.4 m	69.4 m	64.9 m	78.6 m	59 m	77.2 m	83.3 m	62.9 m
Additional Paid-in Capital	228.5 m	231 m	236.3 m	238 m	240 m	212.7 m	205.3 m	208.1 m	208.7 m
Retained Earnings	70.7 m	71.2 m	57 m	60.6 m	59.2 m	66.4 m	59.1 m	67.4 m	61.5 m
Total Equity	305.2 m	305 m		297.7 m	297.2 m	275.5 m	258.2 m	273.2 m	267.1 m
Financial Leverage	1.4 x	1.3 x		1.3 x	1.4 x	1.3 x	1.4 x	1.4 x	1.3 x

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	(25.5 m)	(8.5 m)	(2.8 m)	3.1 m
Depreciation and Amortization		2.3 m	20.9 m	20.8 m
Accounts Receivable	25.7 m	6.1 m	(1.5 m)	392 k
Inventories	(6.6 m)	8.1 m	3.1 m	(5.3 m)
Accounts Payable	(2.3 m)	(6.5 m)	3 m	(1.8 m)
Cash From Operating Activities	66.9 m	51 m	43.2 m	44.7 m
Cash From Investing Activities	(29.7 m)	(20 m)	(38.3 m)	(21.9 m)
Long-term Borrowings	(16 k)	(20 m)	(20 m)	(20 m)
Cash From Financing Activities	(38.4 m)	(20 m)	25.1 m	(46.1 m)
Interest Paid	2 m	1.3 m	852 k	672 k
Income Taxes Paid	8.8 m	2.2 m	3.2 m	4.4 m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Net Income	(683 k)	452 k	(8.4 m)	3.6 m	(1.4 m)	3.9 m	(7.4 m)	9.9 m	(2.7 m)
Depreciation and Amortization	661 k	508 k	405 k
Inventories	70.9 m	64.3 m	56.7 m	59.2 m	57.8 m	59.8 m	61.3 m	65 m	66.3 m
Accounts Payable	15.7 m	13.2 m	16.3 m	17.2 m	17 m	13.5 m	13.7 m	14.4 m	16.6 m

Ratios

USD	Y, 2017
Revenue/Employee	109.5 k
Financial Leverage	1.3 x

Orthofix Market Value History

Market Position of Orthofix

Competitors

Second Sight Medical Products

Health - Public

Compare competitors

Orthofix

Company Growth (employees)

Orthofix Office Locations

Orthofix Data and Metrics

Orthofix Financial Metrics

Summary

Revenue (Q1, 2017)

Gross profit (Q1, 2017)

Gross profit margin (Q1, 2017), %

Net income (Q1, 2017)

EBIT (Q1, 2017)

Market capitalization (25-Jul-2017)

Closing share price (25-Jul-2017)

Cash (31-Mar-2017)

Income Statement

Revenue

Cost of goods sold

Gross profit

Gross profit Margin, %

Sales and marketing expense

R&D expense

General and administrative expense

Operating expense total

EBIT

EBIT margin, %

Interest expense

Interest income

Pre tax profit

Income tax expense

Net Income

Revenue

Cost of goods sold

Gross profit

Gross profit Margin, %

Sales and marketing expense

R&D expense

General and administrative expense

Operating expense total

EBIT

EBIT margin, %

Interest expense

Interest income

Pre tax profit

Income tax expense

Net Income

Balance Sheet

Cash

Accounts Receivable

Inventories

Current Assets

PP&E

Goodwill

Total Assets

Accounts Payable

Current Liabilities

Total Liabilities

Additional Paid-in Capital

Retained Earnings

Total Equity

Financial Leverage

Cash

Inventories

Current Assets

PP&E

Goodwill

Total Assets

Accounts Payable

Current Liabilities

Additional Paid-in Capital

Retained Earnings

Total Equity

Financial Leverage

Cash Flow

Net Income

Depreciation and Amortization

Accounts Receivable

Inventories

Accounts Payable

Cash From Operating Activities

Cash From Investing Activities